XRCC1 Arg399Gln遗传变异增加了结肠直肠癌的易感性:一个全面的元分析
Praveen Kumar Kampalli1, Mohan Krishna Ghanta2, Rishitha Chowdary Mavillapalli3
1Department of Bioscience & Biotechnology, Banasthali University, Rajasthan, India.
Asian Pacific journal of cancer prevention : APJCP
|November 28, 2025
概括
XRCC1 Arg399Gln 多态性与患结直肠癌 (CRC) 的风险更高有关. 然而,其他XRCC1基因变异,Arg194Trp和Arg280His,与CRC风险没有显著关联.
科学领域:
- 遗传学和癌症流行病学
- 分子生物学和疾病风险
背景情况:
- 结肠直肠癌 (CRC) 是全球癌症死亡的主要原因.
- 在DNA修复酶中遗传的遗传变异,如XRCC1,与CRC风险有关.
- 之前对XRCC1多态性和CRC风险的研究已经在不同人群中产生了不一致的结果.
研究的目的:
- 进行全面的元分析,评估三种常见的XRCC1基因多态 (Arg194Trp,Arg280His和Arg399Gln) 与结直肠癌风险之间的关联.
- 综合多项病例控制研究的证据,以澄清XRCC1变异在CRC易感性中的作用.
主要方法:
- 一项元分析,结合了52项独立病例控制研究的数据.
- 具体分析包括Arg194Trp的23项研究,Arg280His的8项研究和Arg399Gln的42项研究.
- 使用统计方法来评估整体风险,并探索潜在的种族差异.
主要成果:
- 在XRCC1 Arg399Gln多态性和结直肠癌风险增加之间发现了统计学上显著的相关性 (OR = 1.10,95% CI = 1.01-1.20).
- 根据种族 (亚洲和高加索人种) 的子组分析没有显示任何研究的XRCC1多态和CRC风险之间存在显著的关联.
- 在元分析中没有发现出版偏差的证据.
结论:
- XRCC1 Arg399Gln多态可能与对结直肠癌的敏感性增加有关.
- XRCC1的Arg194Trp和Arg280H的多态性与结直肠癌风险没有显著关联.
- 可能需要进一步的研究来阐明XRCC1变异在结直肠癌发展中的确切作用.
相关概念视频
Single Nucleotide Polymorphisms-SNPs
17.9K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.9K
Genome-wide Association Studies-GWAS
15.2K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
15.2K


